Bioavailability of AZD0284 and IV microtracer study

Trial Identifier: D7800C00002
Sponsor: AstraZeneca
NCTID:: NCT03029741
Start Date: February 2017
Primary Completion Date: March 2017
Study Completion Date: March 2017
Condition: Psoriasis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
English Translation

Trial Locations

Country Location
United Kingdom Ruddington, United Kingdom, NG11 6JS